Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210428 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-11-16 | 2023-11-23 | 210431 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210434 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210437 |
TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2023-11-23 | 2024-03-28 | 211316 |
TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-11-23 | 2024-01-11 | 211319 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-11-23 | 2023-12-14 | 211322 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211970 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2023-11-30 | 2024-02-15 | 211973 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-11-30 | 2024-01-11 | 211976 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-11-30 | 2024-01-19 | 211979 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211982 |
TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211985 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 211988 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211992 |
ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211998 |
ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 212001 |
RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-12-07 | 2024-01-11 | 212717 |
TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-12-07 | 2024-04-18 | 212725 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
ACT DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |